Does close contact with a patient diagnosed with Neisseria meningitidis require chemoprophylaxis?

Neisseria meningitidis Exposure Prophylaxis

Yes, close contacts of patients with confirmed or probable Neisseria meningitidis infection absolutely require chemoprophylaxis, and this should be initiated as soon as possible, ideally within 24 hours of identifying the index case. 1

Who Qualifies as a Close Contact Requiring Prophylaxis

Close contacts include: 1, 2

• Household members who lived with the patient in the 7 days before symptom onset
• Intimate kissing contacts
• Anyone directly exposed to the patient's oral secretions (through kissing, mouth-to-mouth resuscitation, endotracheal intubation, or endotracheal tube management)
• Child-care center contacts 2
• Healthcare personnel who managed the patient's airway or were exposed to respiratory secretions 2
• Airline passengers seated directly next to the index patient on flights ≥8 hours duration 2

Rationale for Prophylaxis

The risk justification is compelling: 1

• Secondary attack rates in close contacts are 2-4 per 1,000 population - representing a 1,000-fold increase over the general population rate (0.23/100,000 in adults)
• Most patients acquire the invading meningococcus within the previous 7 days before developing systemic disease
• Household contacts show carriage rates of the pathogenic strain of 12.4%, compared to only 0.7% in the general population 3

Recommended Antibiotic Regimens

First-Line: Ciprofloxacin (Single Dose - Preferred) 1

• Adults: 500 mg oral, single dose
• Children 5-12 years: 250 mg oral, single dose
• Children <5 years: 30 mg/kg (maximum 125 mg) oral, single dose

Ciprofloxacin is preferred because it is a single dose and readily available, though this recommendation requires modification in areas with documented ciprofloxacin resistance 1, 4

Alternative: Rifampicin 1

• Adults and children >12 years: 600 mg twice daily for 2 days
• Children 1-12 years: 10 mg/kg twice daily for 2 days
• Infants <12 months: 5 mg/kg twice daily for 2 days

Important caveat: Rifampicin is not recommended in pregnancy due to teratogenicity and may reduce oral contraceptive efficacy 2

Alternative: Ceftriaxone (Single IM Dose) 2

• Adults: 250 mg IM, single dose
• Children <15 years: 125 mg IM, single dose

Emerging Resistance Considerations

Critical update: Since 2019, ciprofloxacin-resistant N. meningitidis strains have increased in the United States 4. Health departments should preferentially use alternatives to ciprofloxacin when BOTH criteria are met in a 12-month rolling period: 4

• ≥2 invasive meningococcal disease cases caused by ciprofloxacin-resistant strains
• ≥20% of all cases are ciprofloxacin-resistant

Dual penicillin and ciprofloxacin resistance (ST-3587 harboring blaROB-1 and gyrA mutations) has emerged in Europe, further complicating prophylaxis choices 5, 6

Timing and Administration

• Initiate prophylaxis <24 hours after identifying the index case for maximum effectiveness 2
• Prophylaxis given >14 days after exposure is of limited or no value 2
• Do NOT delay for oropharyngeal cultures - these are not helpful and unnecessarily postpone treatment 2

Coordination with Public Health

Prophylaxis should be initiated by public health authorities (Consultant in Communicable Disease Control or health protection team), NOT by admitting clinicians, though clinical teams may be asked to arrange prescriptions 1

All cases must be notified to relevant public health authorities - this is a legal obligation in many jurisdictions 1

Additional Vaccination Considerations

Beyond chemoprophylaxis: 1

• Unvaccinated contacts of cases caused by vaccine-preventable non-B serogroups should receive vaccination
• If ≥2 serogroup B cases occur in the same household, consider Bexsero vaccination for all household contacts in addition to chemoprophylaxis 1

Long-Term Risk

An increased risk persists for at least 6 months in contacts despite prophylaxis 1. Medical records of all close contacts should be flagged to alert providers of this ongoing elevated risk 1

When Prophylaxis is NOT Indicated

Chemoprophylaxis is not recommended for: 2

• Contacts of patients with N. meningitidis isolated only from non-sterile sites (oropharyngeal swabs, endotracheal secretions, conjunctival swabs)
• Asymptomatic nasopharyngeal carriers
• Casual contacts without direct exposure to oral secretions